4/10
04:05 pm
lung
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
Low
Report
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
4/3
12:11 pm
lung
Pulmonx Co. (NASDAQ: LUNG) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $17.00 price target on the stock.
Low
Report
Pulmonx Co. (NASDAQ: LUNG) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $17.00 price target on the stock.
4/2
04:17 pm
lung
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer [Yahoo! Finance]
Medium
Report
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer [Yahoo! Finance]
4/2
04:05 pm
lung
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Medium
Report
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
3/26
05:51 am
lung
Pulmonx: Revisiting Thesis Following Management Change [Seeking Alpha]
Medium
Report
Pulmonx: Revisiting Thesis Following Management Change [Seeking Alpha]
3/15
05:08 pm
lung
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/15
05:00 pm
lung
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
2/29
11:42 pm
lung
Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp [Yahoo! Finance]
Low
Report
Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp [Yahoo! Finance]
2/26
08:18 am
lung
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial [Yahoo! Finance]
Medium
Report
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial [Yahoo! Finance]
2/26
08:00 am
lung
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
Medium
Report
Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial
2/24
08:31 am
lung
US$16.50 - That's What Analysts Think Pulmonx Corporation (NASDAQ:LUNG) Is Worth After These Results [Yahoo! Finance]
Medium
Report
US$16.50 - That's What Analysts Think Pulmonx Corporation (NASDAQ:LUNG) Is Worth After These Results [Yahoo! Finance]
2/23
12:15 pm
lung
Pulmonx Co. (NASDAQ: LUNG) had its price target raised by analysts at Citigroup Inc. from $16.00 to $17.00. They now have a "buy" rating on the stock.
Low
Report
Pulmonx Co. (NASDAQ: LUNG) had its price target raised by analysts at Citigroup Inc. from $16.00 to $17.00. They now have a "buy" rating on the stock.
2/23
11:29 am
lung
Pulmonx dips on Wells Fargo downgrade eyeing uncertainty over management changes [Seeking Alpha]
Low
Report
Pulmonx dips on Wells Fargo downgrade eyeing uncertainty over management changes [Seeking Alpha]
2/23
07:11 am
lung
Pulmonx Co. (NASDAQ: LUNG) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $14.00 price target on the stock, down previously from $16.00.
Medium
Report
Pulmonx Co. (NASDAQ: LUNG) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $14.00 price target on the stock, down previously from $16.00.
2/23
06:38 am
lung
Pulmonx Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Pulmonx Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]
2/22
02:31 pm
lung
Pulmonx Co. (NASDAQ: LUNG) had its price target raised by analysts at Piper Sandler from $13.00 to $17.00. They now have an "overweight" rating on the stock.
Medium
Report
Pulmonx Co. (NASDAQ: LUNG) had its price target raised by analysts at Piper Sandler from $13.00 to $17.00. They now have an "overweight" rating on the stock.
2/22
02:31 pm
lung
Pulmonx Co. (NASDAQ: LUNG) had its price target raised by analysts at Stifel Nicolaus from $15.00 to $17.00. They now have a "buy" rating on the stock.
Medium
Report
Pulmonx Co. (NASDAQ: LUNG) had its price target raised by analysts at Stifel Nicolaus from $15.00 to $17.00. They now have a "buy" rating on the stock.
2/22
11:37 am
lung
Pulmonx Co. (NASDAQ: LUNG) had its price target raised by analysts at Wells Fargo & Company from $15.00 to $16.00. They now have an "overweight" rating on the stock.
Low
Report
Pulmonx Co. (NASDAQ: LUNG) had its price target raised by analysts at Wells Fargo & Company from $15.00 to $16.00. They now have an "overweight" rating on the stock.
2/22
10:15 am
lung
Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Pulmonx Corporation (NASDAQ:LUNG) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/21
04:58 pm
lung
Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses [Yahoo! Finance]
High
Report
Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses [Yahoo! Finance]
2/21
04:18 pm
lung
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
High
Report
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
2/21
04:18 pm
lung
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer [Yahoo! Finance]
High
Report
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer [Yahoo! Finance]
2/21
04:06 pm
lung
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
High
Report
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
2/21
04:05 pm
lung
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
High
Report
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
2/21
08:24 am
lung
bioAffinity Technologies News Update [Yahoo! Finance]
Low
Report
bioAffinity Technologies News Update [Yahoo! Finance]